| 1.05 -0.01 (-0.94%) | 08-07 09:30 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 2.9 | 1-year : | 4.49 |
| Resists | First : | 2.48 | Second : | 3.84 |
| Pivot price | 1.71  |
|||
| Supports | First : | 0.28 | Second : | 0.23 |
| MAs | MA(5) : | 1.77 |
MA(20) : | 1.9 |
| MA(100) : | 0.85  |
MA(250) : | 1 |
|
| MACD | MACD : | 0.1 |
Signal : | 0.2 |
| %K %D | K(14,3) : | 28.6 |
D(3) : | 30.4 |
| RSI | RSI(14): 50.1 |
|||
| 52-week | High : | 3.84 | Low : | 0.28 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ IINN ] has closed above bottom band by 40.5%. Bollinger Bands are 40.5% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 23 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 1.66 - 1.68 | 1.68 - 1.69 |
| Low: | 1.44 - 1.46 | 1.46 - 1.47 |
| Close: | 1.59 - 1.62 | 1.62 - 1.64 |
Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacturing, and marketing of proprietary life support technologies for the treatment of acute respiratory failure in Israel. It offers INSPIRA ART100, a life support system used in procedures requiring cardiopulmonary bypass for six hours or less. It also offers additive manufactured electronics platform that enables 3D architecture for systems operating in dilution cryostats. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Inspira Technologies Oxy B.H.N. Ltd. was incorporated in 2018 and is headquartered in Ra'anana, Israel.
Wed, 19 Aug 2026
QTREX turns printed insulation into conductive carbon in all 20 laser tests - Stock Titan
Wed, 20 May 2026
Inspira Technologies to Begin Trading as QTREX Quantum Under Nasdaq Ticker "QTEX" - The Quantum Insider
Tue, 19 May 2026
Inspira targets quantum connectivity bottleneck, rebrands as QTREX Quantum - Stock Titan
Tue, 19 May 2026
Inspira Technologies Rebrands as QTREX Quantum and Changes Nasdaq Ticker to QTEX - Yahoo Finance
Mon, 18 May 2026
Inspira Technologies receives $580,000 order from NYU Langone By Investing.com - Investing.com Nigeria
Mon, 18 May 2026
NYU Langone adopts new blood-circulation system after 30-patient trial - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 0 (M) |
| Shares Float | 44 (M) |
| Held by Insiders | 3.237e+007 (%) |
| Held by Institutions | 10.2 (%) |
| Shares Short | 360 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -1.347e+007 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -4 % |
| Return on Assets (ttm) | 713.8 % |
| Return on Equity (ttm) | -127 % |
| Qtrly Rev. Growth | 289000 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | -184.21 |
| EBITDA (p.s.) | 925.92 |
| Qtrly Earnings Growth | -0.5 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -10 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | -0.01 |
| Price to Cash Flow | 57.96 |
| Dividend | 0 |
| Forward Dividend | 906790 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|